Otsuka Pharmaceutical Companies (U.S.)

Otsuka Pharmaceutical Companies (U.S.) is the American division of Otsuka Holdings Co., Ltd., a global healthcare group founded in Japan in 1921. With over 180 companies and 45,000 employees worldwide, Otsuka focuses on innovative pharmaceuticals, medical devices, and healthcare services. The U.S. operations, established in 1985, are headquartered in Princeton, NJ, and employ around 3,511 people, reporting $675.1 million in revenue in 2024. The company develops and commercializes products across various therapeutic areas, including neuroscience, oncology, nephrology, and immunology. Its offerings include treatments for mental health disorders, cancer, and kidney diseases, as well as nutraceuticals and medical devices. Otsuka emphasizes creativity and innovation to meet unmet medical needs and supports patients through various health and well-being programs. Key services include pharmaceutical research, drug discovery, clinical development, and healthcare innovation, targeting patients and healthcare providers globally.